| consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases N Mitrev, N Vande Casteele, CH Seow, JM Andrews, SJ Connor, ... Alimentary pharmacology & therapeutics 46 (11-12), 1037-1053, 2017 | 281 | 2017 |
| Smoking prevalence and its influence on disease course and surgery in Crohn's disease and ulcerative colitis PC Lunney, VC Kariyawasam, RR Wang, KL Middleton, T Huang, ... Alimentary pharmacology & therapeutics 42 (1), 61-70, 2015 | 116 | 2015 |
| Giant laterally spreading tumors of the duodenum: endoscopic resection outcomes, limitations, and caveats SB Fanning, MJ Bourke, SJ Williams, A Chung, VC Kariyawasam Gastrointestinal Endoscopy 75 (4), 805-812, 2012 | 92 | 2012 |
| Inflammatory bowel disease environmental risk factors: a population-based case–control study of Middle Eastern migration to Australia Y Ko, V Kariyawasam, M Karnib, R Butcher, D Samuel, A Alrubaie, ... Clinical Gastroenterology and Hepatology 13 (8), 1453-1463. e1, 2015 | 91 | 2015 |
| Ulcerative colitis and cytomegalovirus infection: from A to Z FH Mourad, JG Hashash, VC Kariyawasam, RW Leong Journal of Crohn's and Colitis 14 (8), 1162-1171, 2020 | 85 | 2020 |
| acute severe ulcerative colitis–evidence‐based consensus statements JH Chen, JM Andrews, V Kariyawasam, N Moran, P Gounder, G Collins, ... Alimentary pharmacology & therapeutics 44 (2), 127-144, 2016 | 75 | 2016 |
| Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitis RWL Leong, T Huang, Y Ko, A Jeon, J Chang, F Kohler, V Kariyawasam Journal of Crohn's and Colitis 8 (10), 1237-1245, 2014 | 70 | 2014 |
| Prevalence and Risk Factors for Functional Vitamin B12 Deficiency in Patients with Crohn's Disease MG Ward, VC Kariyawasam, SB Mogan, KV Patel, M Pantelidou, ... Inflammatory bowel diseases 21 (12), 2839-2847, 2015 | 67 | 2015 |
| Complete Barrett’s excision by stepwise endoscopic resection in short-segment disease: long term outcomes and predictors of stricture A Chung, MJ Bourke, LF Hourigan, G Lim, A Moss, SJ Williams, ... Endoscopy 43 (12), 1025-1032, 2011 | 67 | 2011 |
| Circumferential location predicts the risk of high-grade dysplasia and early adenocarcinoma in short-segment Barrett's esophagus VC Kariyawasam, MJ Bourke, LF Hourigan, G Lim, A Moss, SJ Williams, ... Gastrointestinal endoscopy 75 (5), 938-944, 2012 | 65 | 2012 |
| Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease VC Kariyawasam, CP Selinger, PH Katelaris, DB Jones, C McDonald, ... Inflammatory bowel diseases 20 (8), 1382-1390, 2014 | 58 | 2014 |
| Depression, anxiety and stress among patients with inflammatory bowel disease during the COVID-19 pandemic: Australian national survey M Cheema, N Mitrev, L Hall, M Tiongson, G Ahlenstiel, V Kariyawasam BMJ open gastroenterology 8 (1), e000581, 2021 | 54 | 2021 |
| Medication non-adherence in inflammatory bowel diseases is associated with disability J Perry, A Chen, V Kariyawasam, G Collins, C Choong, WL Teh, N Mitrev, ... Intestinal research 16 (4), 571-578, 2018 | 52 | 2018 |
| Major abdominal and perianal surgery in Crohn’s disease: long-term follow-up of Australian patients with Crohn’s disease JWT Toh, N Wang, CJ Young, MJFX Rickard, A Keshava, P Stewart, ... Diseases of the Colon & Rectum 61 (1), 67-76, 2018 | 42 | 2018 |
| Safety of drugs used for the treatment of Crohn’s disease A Pudipeddi, V Kariyawasam, C Haifer, B Baraty, S Paramsothy, ... Expert Opinion on Drug Safety 18 (5), 357-367, 2019 | 37 | 2019 |
| Thioguanine in inflammatory bowel disease: long-term efficacy and safety MG Ward, KV Patel, VC Kariyawasam, R Goel, B Warner, TR Elliott, ... United European Gastroenterology Journal 5 (4), 563-570, 2017 | 36 | 2017 |
| Review of exclusive enteral therapy in adult Crohn’s disease N Mitrev, H Huang, B Hannah, VC Kariyawasam BMJ open gastroenterology 8 (1), e000745, 2021 | 33 | 2021 |
| Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort K Liu, R Wang, V Kariyawasam, M Wells, SI Strasser, G McCaughan, ... Liver International 37 (3), 442-448, 2017 | 33 | 2017 |
| Thiopurines dosed to a therapeutic 6-thioguanine level in combination with adalimumab are more effective than subtherapeutic thiopurine-based combination therapy or adalimumab … VC Kariyawasam, MG Ward, PA Blaker, KV Patel, R Goel, JD Sanderson, ... Inflammatory Bowel Diseases 23 (9), 1555-1565, 2017 | 28 | 2017 |
| Comorbidities rather than age are associated with the use of immunomodulators in elderly-onset inflammatory bowel disease VC Kariyawasam, S Kim, FH Mourad, CP Selinger, PH Katelaris, ... Inflammatory Bowel Diseases 25 (8), 1390-1398, 2019 | 25 | 2019 |
Rupert W Leong (R W Leong)University of Sydney, Concord Repatriation HospitalVerified email at sydney.edu.au
